Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI

We determined the cardiologic features of children with MPS I, II and VI, and evaluated the effect of enzyme-replacement therapy (ERT) on cardiac disease. Twenty-four children aged 1-18 years with MPS I, II or VI were prospectively evaluated with echocardiogram and electrocardiogram from the start o...

Descripción completa

Detalles Bibliográficos
Autores principales: Brands, Marion M. M. G., Frohn-Mulder, Ingrid M., Hagemans, Marloes L. C., Hop, Wim C. J., Oussoren, Esmee, Helbing, Wim A., van der Ploeg, Ans T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590414/
https://www.ncbi.nlm.nih.gov/pubmed/22278137
http://dx.doi.org/10.1007/s10545-011-9444-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590414/
https://www.ncbi.nlm.nih.gov/pubmed/22278137
http://dx.doi.org/10.1007/s10545-011-9444-z

Ejemplares similares